抗发作药物用于预防大脑瘤成年人的第一次发作
Laura White1,2, Nicole Mooney3, Mohammad A Mustafa4
1Lancaster Medical School, Lancaster University, Lancaster, UK.
The Cochrane database of systematic reviews
|July 2, 2025
概括
本审查协议概述了对抗发作药物 (ASM) 进行的评估,以预防脑瘤患者的第一次发作. 它将ASM与安慰剂或没有治疗进行比较,以确定疗效和耐受性.
科学领域:
- 神经瘤学神经瘤学
- 临床药理学 临床药理学
- 基于证据的医学基于证据的医学.
背景情况:
- 大脑瘤与新发作发作的显著风险有关.
- 在这个人群中预防第一次发作可能会改善生活质量并促进治疗.
- 目前关于抗发作药物 (ASM) 预防性使用的证据有限.
研究的目的:
- 系统地评估ASM在预防脑瘤患者首次发作的疗效.
- 评估ASM在预防性使用时的耐受性和安全性.
- 为了比较ASM与安慰剂或没有活性治疗干预措施.
主要方法:
- 这是一个可克兰审查 (干预) 的协议.
- 该审查将综合随机对照试验 (RCT) 和其他相关研究设计的证据.
- 将提取关于发病率,不良事件和生活质量的数据.
主要成果:
- 在审查完成后,本部分将报告调查结果.
- 预期的结果将详细说明ASM在预防发作的有效性.
- 预期的结果还将涵盖不同ASM的副作用概况.
结论:
- 这一综述将为ASM在脑瘤患者的发作预防中的作用提供关键的见解.
- 结果将为临床指导方针和治疗决策提供信息.
- 这项研究旨在澄清预防性ASM的好处是否超过了这一特定人群的风险.
相关概念视频
Antiepileptic Drugs: Sodium Channel Blockers
927
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
927
Epilepsy and Seizures: Overview
293
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
293
Antiepileptic Drugs: Calcium Channel Blockers
648
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
648
Antiepileptic Drugs: Glutamate Antagonists
526
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
526
Antiepileptic Drugs: GABAergic Pathway Potentiators
671
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
671
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
459
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
459


